Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Compare regional ETFs by cash flow to find the strongest income generator. A quick guide to optimize regional yield strategies.
26,816 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
A high-profile insider sale at a growing regional bank has investors weighing motives and market signals. This guide ...
Target shares surged to a fresh all-time high after a robust Q1 report, sparking questions about how long the rally c...
SpaceX kicked off a $25 billion bond offering just weeks after a historic $75 billion IPO, while its stock trades wel...
Meta Platforms faces a choppy start to July 2026, but a fresh meta stock price prediction points to meaningful upside...
Bitdeer, a leading Bitcoin miner, has sold its entire BTC stash, signaling a strategic pivot that could influence nea...
SpaceX begins trading on Nasdaq, positioning Elon Musk for trillionaire status as investors bet on a bold, multi-plan...
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
A fintech founder chose financial discipline over prestige, turning down an invitation from President Obama to focus ...
Shake Shack delivered a blowout Q4, where earnings beat expectations by a wide margin and revenue surged. The company...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A rumored $111 billion Paramount Warner Bros' deal could fuse studios, streaming, and networks under a private group,...